Ryan Blust - 06 Mar 2025 Form 3 Insider Report for Trulieve Cannabis Corp. (TCNNF)

Role
Interim CFO
Signature
/s/ Ryan Blust
Issuer symbol
TCNNF
Transactions as of
06 Mar 2025
Net transactions value
$0
Form type
3
Filing time
11 Mar 2025, 16:11:46 UTC
Previous filing
16 Jan 2024
Next filing
28 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TRUL Subordinate Voting Shares 54,298 06 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TRUL Stock Option (Right to Buy) 06 Mar 2025 Subordinate Voting Shares 7,497 $33.42 Direct F2
holding TRUL Stock Option (Right to Buy) 06 Mar 2025 Subordinate Voting Shares 19,458 $26.88 Direct F3
holding TRUL Stock Option (Right to Buy) 06 Mar 2025 Subordinate Voting Shares 24,860 $21.48 Direct F4
holding TRUL Stock Option (Right to Buy) 06 Mar 2025 Subordinate Voting Shares 56,442 $3.99 Direct F5
holding TRUL Stock Option (Right to Buy) 06 Mar 2025 Subordinate Voting Shares 33,114 $10.00 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The amount of securities beneficially owned in column 2 includes two grants of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. subordinate voting share. The reporting person was granted: (i) 25,364 RSUs on July 25, 2023, subject to 2-year vesting; the RSUs vested 50% on December 1, 2024 and will vest 50% on December 1, 2025; and (ii) 18,288 RSUs on March 8, 2024, subject to 2-year vesting; the RSUs will vest 50% on December 1, 2025 and 50% on December 1, 2026.
F2 The options were granted on January 4, 2021. As of December 31, 2023, all of the options were fully vested and exercisable.
F3 The options were granted on September 29, 2021. As of December 1, 2023, all of the options were fully vested and exercisable.
F4 The options were granted on February 24, 2022. As of December 1, 2024, all of the options were fully vested and exercisable.
F5 The options were granted on July 25, 2023, and vest 33% per year in equal installments, starting on December 1 of the grant year. One third of the options vested and became exercisable on December 1, 2023; one third of the options vested and became exercisable on December 1, 2024; and one third of the options will vest and become exercisable on December 1, 2025.
F6 The options were granted on March 8, 2024, and vest 33% per year in equal installments, starting on December 1 of the grant year. One third of the options vested and became exercisable on December 1, 2024; one third of the options will vest and become exercisable on December 1, 2025; and one third of the options will vest and become exercisable on December 1, 2026.